Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.

Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation

Open access
Phan, Joann, Nair, Divya, Jain, Suneer, Montagne, Thibaut, Flores, Demi Valeria, Nguyen, Andre, Dietsche, Summer, Gombar, Saurabh, Cotter, Philip · 2021 · mSystems

Published version of a preprint

Abstract

An estimated 35 million people in the United States and 11.5% of the population globally are affected by IBS. Immunity, genetics, environment, diet, small intestinal bacterial overgrowth (SIBO), and the gut microbiome are all factors that contribute to the onset or triggers of IBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/msystems.01215-21

Cites

97 of 97 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Microbiome profiles of the healthy and IBS cohorts. (a) Principal-coordinate analysis based on the Bray-Curtis dissimilarity distance matrix of the IBS and healthy microbiomes. (b) A Random Forest analysis was employed to differentiate microbes between healthy and IBS subtypes. The density of microbes selected from Random Forest analysis corresponds to the sample distribution along the PCO1 axis. (c) Boxplot of the microbiome distributions along the PCO1 axis. An unpaired t test was computed. Open circle data points are outliers outside 1.5 times the interquartile range. (d) Shannon index between healthy and each IBS subtype cohort. Open-circle data points are outliers outside 1.5 times the interquartile range. Unpaired t tests were conducted, and P values were adjusted with Benjamini-Hochberg false-discovery rate (FDR) for multiple comparisons. *, P < 0.05; ****, P < 0.0001.
FIG 1 Microbiome profiles of the healthy and IBS cohorts. (a) Principal-coordinate analysis based on the Bray-Curtis dissimilarity distance matrix of the IBS and healthy microbiomes. (b) A Random Forest analysis was employed to differentiate microbes between healthy and IBS subtypes. The density of microbes selected from Random Forest analysis corresponds to the sample distribution along the PCO1 axis. (c) Boxplot of the microbiome distributions along the PCO1 axis. An unpaired t test was computed. Open circle data points are outliers outside 1.5 times the interquartile range. (d) Shannon index between healthy and each IBS subtype cohort. Open-circle data points are outliers outside 1.5 times the interquartile range. Unpaired t tests were conducted, and P values were adjusted with Benjamini-Hochberg false-discovery rate (FDR) for multiple comparisons. *, P < 0.05; ****, P < 0.0001.CC BY · PubMed Central
FIG 2 Microbes and pathways that differentiate healthy and IBS cohorts. (a) Log base 10 of relative abundances of the microbes associated with healthy and IBS populations. A Random Forest analysis was used to determine microbes that contribute to differentiating healthy and IBS subjects. The relative abundances of a subset of the microbes were plotted for healthy subjects and each IBS subtype. Open-circle data points are outliers outside 1.5 times the interquartile range. t tests were calculated. P values were adjusted for multiple-comparison testing by false-discovery rate corrections. Nonsignificant comparisons were omitted. (b) Functional pathways associated with healthy and IBS gut microbiomes. Multivariate linear association testing with Maaslin2 was used to determine pathways associated with IBS relative to the healthy control population. Values indicate the beta coefficient from linear association testing. Pathways listed were filtered based on a q value of <0.1 and beta coefficients of >0.2 or <−0.2. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.
FIG 2 Microbes and pathways that differentiate healthy and IBS cohorts. (a) Log base 10 of relative abundances of the microbes associated with healthy and IBS populations. A Random Forest analysis was used to determine microbes that contribute to differentiating healthy and IBS subjects. The relative abundances of a subset of the microbes were plotted for healthy subjects and each IBS subtype. Open-circle data points are outliers outside 1.5 times the interquartile range. t tests were calculated. P values were adjusted for multiple-comparison testing by false-discovery rate corrections. Nonsignificant comparisons were omitted. (b) Functional pathways associated with healthy and IBS gut microbiomes. Multivariate linear association testing with Maaslin2 was used to determine pathways associated with IBS relative to the healthy control population. Values indicate the beta coefficient from linear association testing. Pathways listed were filtered based on a q value of <0.1 and beta coefficients of >0.2 or <−0.2. *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001.CC BY · PubMed Central
FIG 3 Longitudinal microbiome diversity and relative abundances of probiotics in subjects with IBS. (a) Shannon index of the microbiome composition from subjects with time points 1 to 3. (b) Bray-Curtis similarity of time points within each individual. Each time point is compared to each subsequent time point. (c) Relative abundances of probiotic species detected in the gut microbiome of subjects across 3 time points. t tests were computed with false-discovery rate (FDR)-adjusted P values. *, P value < 0.05; **, P value < 0.01; ****, P value < 0.0001; ns, not significant.
FIG 3 Longitudinal microbiome diversity and relative abundances of probiotics in subjects with IBS. (a) Shannon index of the microbiome composition from subjects with time points 1 to 3. (b) Bray-Curtis similarity of time points within each individual. Each time point is compared to each subsequent time point. (c) Relative abundances of probiotic species detected in the gut microbiome of subjects across 3 time points. t tests were computed with false-discovery rate (FDR)-adjusted P values. *, P value < 0.05; **, P value < 0.01; ****, P value < 0.0001; ns, not significant.CC BY · PubMed Central
FIG 4 Microbial features associated with each IBS subtype. (a) Venn diagram of unique and shared microbes from Random Forest analysis comparing healthy subjects and each IBS subtype. (b to d) The relative abundances of microbes across longitudinal healthy subjects and IBS subtypes. Microbes were determined by Random Forest analysis between healthy subjects and IBS subtype and selected based on a significant change across IBS subtype time points. Microbes with significant change across time in IBS-A (b), IBS-D (c), and IBS-U (d) cohorts.
FIG 4 Microbial features associated with each IBS subtype. (a) Venn diagram of unique and shared microbes from Random Forest analysis comparing healthy subjects and each IBS subtype. (b to d) The relative abundances of microbes across longitudinal healthy subjects and IBS subtypes. Microbes were determined by Random Forest analysis between healthy subjects and IBS subtype and selected based on a significant change across IBS subtype time points. Microbes with significant change across time in IBS-A (b), IBS-D (c), and IBS-U (d) cohorts.CC BY · PubMed Central
FIG 5 Microbial features associated with each IBS subtype. (a) Venn diagram of unique and shared pathways from Random Forest analysis comparing healthy subjects and each IBS subtype. (b) The copies per million of pathways across longitudinal IBS-C subtypes determined by Random Forest analysis.
FIG 5 Microbial features associated with each IBS subtype. (a) Venn diagram of unique and shared pathways from Random Forest analysis comparing healthy subjects and each IBS subtype. (b) The copies per million of pathways across longitudinal IBS-C subtypes determined by Random Forest analysis.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 97 references

Cited by

See all 33

Metadata

Authors
Phan, J., Nair, D., Jain, S., Montagne, T., Flores, D. V., Nguyen, A., Dietsche, S., Gombar, S., & Cotter, P.
Affiliations
  • Sun Genomics, Inc., San Diego, California, USA
  • Atropos Health, Palo Alto, California, USA
  • ResearchDx, Inc., Irvine, California, USA
Corresponding author
Phan, Joann
Venue
mSystems
Published
2021-12-21
Volume
6
Issue
6
Pages
e0121521-e0121521
ISSN
2379-5077 (ISSN-L)
OpenAlex
W3211292548
Cited by
33
References
97
Citations by year
2026: 3 · 2025: 7 · 2024: 12 · 2023: 8 · 2022: 3
FWCI
1.81
Type
journal article
Language
en
Open access
Licence
Locations
  • mSystems (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
Keywords
irritable bowel syndrome, gut microbiota, probiotics, probiotic supplementation, small intestinal bacterial overgrowth, microbiota composition, microbiome function, IBS symptom severity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation. https://app.cochat.ai/papers/10.1128/msystems.01215-21
The paper
Phan, J., Nair, D., Jain, S., Montagne, T., Flores, D. V., Nguyen, A., Dietsche, S., Gombar, S., & Cotter, P. (2021). Alterations in Gut Microbiome Composition and Function in Irritable Bowel Syndrome and Increased Probiotic Abundance with Daily Supplementation. mSystems. https://doi.org/10.1128/msystems.01215-21

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.